Literature DB >> 15663913

Peripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetes.

Bart E Muhs1, Paul Gagne, Peter Sheehan.   

Abstract

Peripheral arterial disease (PAD) is an under-recognized complication of diabetes. Recently, prevalence estimates in patients with diabetes over 50 years of age have been placed at 25% to 30%. The main reason for under-reporting is the largely asymptomatic nature of PAD in diabetes. Nonetheless, it is important to diagnose PAD because it is a marker of systemic atherosclerosis with excess cardiovascular risk, and it may identify a patient who may develop progressive disability and risk of limb loss. The most sensitive and specific diagnostic tool is an ankle-brachial index. Imaging studies are performed in patients who are candidates for revascularization. The most durable and effective revascularization procedure for PAD in diabetes is surgical bypass with saphenous vein as the conduit. Endovascular interventions are best used in patients with proximal disease with short-segment stenoses. The indications for revascularization have been immutable for decades, namely rest pain, ischemic ulceration, or gangrene. Presently, clinicians would include "selected" patients with intermittent claudication who have disabling symptoms and proximal disease above the inguinal ligament.

Entities:  

Mesh:

Year:  2005        PMID: 15663913     DOI: 10.1007/s11892-005-0063-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  40 in total

1.  Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results.

Authors:  H Vraux; F Hammer; R Verhelst; P Goffette; B Vandeleene
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-11       Impact factor: 7.069

2.  Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial.

Authors:  J C Palmaz; J C Laborde; F J Rivera; C E Encarnacion; J D Lutz; J G Moss
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

3.  Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation.

Authors:  A Bolia; J Brennan; P R Bell
Journal:  Clin Radiol       Date:  1989-05       Impact factor: 2.350

Review 4.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.

Authors:  J I Weitz; J Byrne; G P Clagett; M E Farkouh; J M Porter; D L Sackett; D E Strandness; L M Taylor
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

5.  Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results.

Authors:  N J London; R Srinivasan; A R Naylor; T Hartshorne; D A Ratliff; P R Bell; A Bolia
Journal:  Eur J Vasc Surg       Date:  1994-03

6.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

7.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 8.  Detailed protocol of ischemia and the use of noninvasive vascular laboratory testing in diabetic foot ulcers.

Authors:  Victoria J Teodorescu; Christopher Chen; Nicholas Morrissey; Peter L Faries; Michael L Marin; Larry H Hollier
Journal:  Am J Surg       Date:  2004-05       Impact factor: 2.565

9.  Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial.

Authors:  E S van der Zaag; D A Legemate; M H Prins; J A Reekers; M J Jacobs
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-08       Impact factor: 7.069

Review 10.  Assessment and management of foot disease in patients with diabetes.

Authors:  G M Caputo; P R Cavanagh; J S Ulbrecht; G W Gibbons; A W Karchmer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

View more
  7 in total

1.  Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes.

Authors:  Jeremy D Darling; Thomas C F Bodewes; Sarah E Deery; Raul J Guzman; Mark C Wyers; Allen D Hamdan; Hence J Verhagen; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-09-22       Impact factor: 4.268

2.  [Imaging in syndrome complex diabetes mellitus: Current standards and future perspectives].

Authors:  H Hetterich; A Schafnitzel; F Bamberg
Journal:  Radiologe       Date:  2015-04       Impact factor: 0.635

3.  Active smoking is associated with higher rates of incomplete wound healing after endovascular treatment of critical limb ischemia.

Authors:  Damianos G Kokkinidis; Stefanos Giannopoulos; Moosa Haider; Timothy Jordan; Anita Sarkar; Gagan D Singh; Eric A Secemsky; Jay Giri; Joshua A Beckman; Ehrin J Armstrong
Journal:  Vasc Med       Date:  2020-05-27       Impact factor: 3.239

Review 4.  Contemporary evaluation and management of the diabetic foot.

Authors:  Bauer E Sumpio
Journal:  Scientifica (Cairo)       Date:  2012-10-09

Review 5.  Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot.

Authors:  Qinan Wu; Bing Chen; Ziwen Liang
Journal:  Stem Cells Int       Date:  2016-10-27       Impact factor: 5.443

6.  Wound Closure in Smoking Peripheral Arterial Disease Patients With Treatment-Refractory Ulcerations: A 12-Month Follow-up Case Series.

Authors:  Jonathan Smedley; Georgina M Michael; Yeabsera G Tamire
Journal:  Int J Low Extrem Wounds       Date:  2016-11-16       Impact factor: 2.057

7.  Risk factors in abdominal aortic aneurysm and in Polish population aortoiliac occlusive disease and differences between them [corrected].

Authors:  Joanna Mikołajczyk-Stecyna; Aleksandra Korcz; Marcin Gabriel; Katarzyna Pawlaczyk; Grzegorz Oszkinis; Ryszard Słomski
Journal:  Sci Rep       Date:  2013-12-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.